Formycon Builds On Middle Eastern Ranibizumab Plans With Saudi Approval
Lucentis Biosimilar Launch In Saudi Arabia Planned In The Second Quarter
After last year’s launch in Jordan, Formycon and partner MS Pharma are now planning the second launch in the Middle East, with more to come later in 2024.
